Home/Filings/3/0001104659-23-035605
3//SEC Filing

Juvenescence US Corp. 3

Accession 0001104659-23-035605

CIK 0001708599other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:19 PM ET

Size

4.0 KB

Accession

0001104659-23-035605

Insider Transaction Report

Form 3
Period: 2023-03-14
Juvenescence US Corp.
Director10% Owner
Holdings
  • Common Stock

    16,447,500
Footnotes (1)
  • [F1]Shares acquired pursuant to a transfer of securities from the reporting person's sole stockholder, Juvenescence Limited.

Issuer

AgeX Therapeutics, Inc.

CIK 0001708599

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001970258

Filing Metadata

Form type
3
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:19 PM ET
Size
4.0 KB